Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Bonatti, H; Brandacher, G; Boesmueller, C; Cont, M; Hengster, P; Rosenkranz, AR; Krugmann, J; Margreiter, R.
Hemolytic uremic syndrome following Campath-1H induction.
Transpl Int. 2007; 20(4):386-389
Doi: 10.1111/j.1432-2277.2006.00445.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Rosenkranz Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Antibodies, Monoclonal - adverse effects
- Antibodies, Neoplasm - adverse effects
- Hemolytic-Uremic Syndrome - chemically induced Hemolytic-Uremic Syndrome - drug therapy
- Humans -
- Immunosuppressive Agents - adverse effects
- Kidney Transplantation - adverse effects
- Male -
- Plasma Exchange -
- Sirolimus - therapeutic use
- Tacrolimus - therapeutic use
- Find related publications in this database (Keywords)
- renal transplantation
- Campath-1H
- haemolytic uremic syndrome
- Rapamycin